Tuesday, March 31, 2026 | 12:44 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 10 - Q3 Results

MTAR Tech surges 49% in 12 days, zooms 156% from August low; here's why

With strong growth visibility over the next few years, the MTAR management has increased its FY26 revenue growth guidance to 30-35% and maintained its EBITDA margin outlook at around 21%.

MTAR Tech surges 49% in 12 days, zooms 156% from August low; here's why
Updated On : 10 Feb 2026 | 9:46 AM IST

Q3 result: Titan, Britannia, Eicher Motors, Finolex, and 308 more on Feb 10

Q3FY26 company results: Firms including Britannia, Apollo Hospitals Enterprise, Jubilant FoodWorks, Escorts Kubota and Oil India are also to release their October-December earnings today

Q3 result: Titan, Britannia, Eicher Motors, Finolex, and 308 more on Feb 10
Updated On : 10 Feb 2026 | 9:19 AM IST

How will HUL fare in Q3 post-ice cream biz demerger? Analysts weigh

Brokerages tracked by Business Standard estimate HUL's net profit to average ₹2,568.5 crore, compared to ₹2,541 crore a year ago, up 1 per cent year-on-year (Y-o-Y)

How will HUL fare in Q3 post-ice cream biz demerger? Analysts weigh
Updated On : 10 Feb 2026 | 8:46 AM IST

Stocks to Watch today: Aurobindo Pharma, BSE, Eternal, Pfizer, Trident

Stocks to watch today, Tuesday, February 10, 2026: Aurobindo Pharma, BSE, Eternal, Pfizer, and Trident shares are in focus on Tuesday

Stocks to Watch today: Aurobindo Pharma, BSE, Eternal, Pfizer, Trident
Updated On : 10 Feb 2026 | 8:14 AM IST

BSE Q3 results: Profit jumps nearly threefold to ₹602 cr; revenue up 62%

Leading stock exchange BSE on Monday reported a nearly three times jump in consolidated profit to Rs 602 crore for the December quarter, driven by strong growth in equity derivatives trading, listings and mutual fund transactions. The exchange posted a profit of Rs 220 crore in the corresponding period of the last fiscal year. Total revenue for the quarter under review stood at an all-time high of Rs 1,334 crore, up 61 per cent from Rs 829 crore a year earlier, BSE said in a statement. This also marks the exchange's 11th consecutive record performance. Further, operating expenses declined 4 per cent year-on-year to Rs 512 crore, further boosting profitability. Investment and other income increased 47 per cent to Rs 90 crore during the quarter. Commenting on the results, BSE MD and CEO Sundararaman Ramamurthy said the exchange's "strong Q3 performance is a testament to the strength of our platforms and the confidence the marketplaces in BSE". "With record SME listings, growing ind

BSE Q3 results: Profit jumps nearly threefold to ₹602 cr; revenue up 62%
Updated On : 09 Feb 2026 | 10:36 PM IST

The Ramco Cements Q3 net profit jumps 2-fold to ₹385.63 cr, revenue up 6%

The Ramco Cements Ltd on Monday reported an over two-fold jump year-on-year in its consolidated net profit at Rs 385.63 crore in the December quarter of FY26, helped by improvement in cement prices and operational efficiencies. The company posted a net profit of Rs 181.58 crore during the October-December quarter of the previous fiscal, according to a regulatory filing by The Ramco Cements. Revenue from operations was up 6.16 per cent to Rs 2,105.68 crore in the December quarter of FY26. It was at Rs 1,983.45 crore in the corresponding period of the previous fiscal. "During Q3 FY26, the cement sale volume is 4.43 million tonnes, compared to 4.28 million tonnes in Q3 FY25 with a growth of 4 per cent," the company said in its earnings statement. The construction chemical business registered a sale volume of 1.54 lakh tonnes for Q3FY26 as against 0.86 lakh tonnes during Q3FY25, registering a growth of 79 per cent. "The overall sale volume for the current quarter has increased by 5 pe

The Ramco Cements Q3 net profit jumps 2-fold to ₹385.63 cr, revenue up 6%
Updated On : 09 Feb 2026 | 10:32 PM IST

BSE PAT zooms 2.74x; Sebi seeks to cut minimum investment for social funds

The exchange's revenue from operations also soared by 62 per cent to ₹1,244 crore year-on-year

BSE PAT zooms 2.74x; Sebi seeks to cut minimum investment for social funds
Updated On : 09 Feb 2026 | 10:31 PM IST

Bata India Q3 net profit up 12.6% at ₹66.1 cr, revenue rises 2.8%

Leading shoemaker Bata India Ltd on Monday reported a 12.61 per cent rise in consolidated net profit to Rs 66.1 crore in the December quarter of FY'26 compared to the year-ago period. It had posted a net profit of Rs 58.7 crore in the previous October-December a year ago, according to a regulatory filing from Bata India. Bata's revenue from operations was up 2.81 per cent to Rs 944.68 crore during the quarter under review compared to Rs 918.79 crore in the corresponding quarter a year ago. Its total expenses in the December quarter were at Rs 868.92 crore, up 3.3 per cent on a year-on-year basis. Bata India's total income, which includes other income, was up 3.93 per cent to Rs 965.72 crore. Shares of Bata India Ltd on Monday settled at Rs 884.35 apiece on BSE, up 4.27 per cent.

Bata India Q3 net profit up 12.6% at ₹66.1 cr, revenue rises 2.8%
Updated On : 09 Feb 2026 | 9:48 PM IST

SBI shares hit record high after Q3; brokerages raise target up to ₹1,300

SBI shares hit a fresh all-time high after Q3FY26 results beat estimates. Brokerages raise earnings forecasts and target prices to ₹1,300, maintaining buy calls

SBI shares hit record high after Q3; brokerages raise target up to ₹1,300
Updated On : 09 Feb 2026 | 9:47 PM IST

Aurobindo Pharma Q3FY26 results: Net profit rises 8% to ₹910 crore

Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to Rs 910 crore for the December quarter, led by robust sales in Europe and the US. The Hyderabad-based drug major reported a net profit of Rs 846 crore for the October-December period of the last fiscal year. Total revenue from operations increased to Rs 8,646 crore during the quarter as compared with Rs 7,979 crore in the year-ago period, the drug firm said in a statement. "Q3 reflected steady execution across Aurobindo's core businesses, supported by stable demand and the strength of our diversified product portfolio in key markets, including the US and Europe," Aurobindo Pharma Vice-Chairman and MD K Nithyananda Reddy said. Growth remained measured, with continued focus on operational discipline and a balanced approach to growth and profitability, he added. "As we progress our strategic initiatives, we remain cautious yet confident in our ability to support sustainable value creation

Aurobindo Pharma Q3FY26 results: Net profit rises 8% to ₹910 crore
Updated On : 09 Feb 2026 | 9:02 PM IST

Zydus Lifesciences Q3 net profit rises 9% on strong US and India growth

Zydus Lifesciences posted higher Q3 profit and revenue, aided by strong growth in the US and India businesses, improved margins, and steady momentum in generics, specialty and chronic segments

Zydus Lifesciences Q3 net profit rises 9% on strong US and India growth
Updated On : 09 Feb 2026 | 7:04 PM IST

Sky Gold and Diamonds posts over twofold jump in Q3 profit at ₹81 cr

Sky Gold and Diamonds Ltd on Monday reported more than twofold jump in consolidated profit to Rs 80.53 crore for the December quarter. Its net profit stood at Rs 36.53 crore in the year-ago period. Total income rose to Rs 1,775.12 crore during the October-December period of the fiscal year from Rs 1,005.09 crore in the corresponding period of the preceding year, according to a regulatory filing. Established in 2008, Mumbai-based Sky Gold and Diamonds Ltd is a B2B jewellery manufacturers, specialising in lightweight, design-led and studded jewellery. The company serves India's leading jewellery retailers and is expanding into global markets.

Sky Gold and Diamonds posts over twofold jump in Q3 profit at ₹81 cr
Updated On : 09 Feb 2026 | 6:14 PM IST

Public sector banks post 18% growth to record ₹52,603 cr profit in Q3 FY26

Led by the country's biggest lender State Bank of India (SBI), public sector banks logged a record cumulative profit of Rs 52,603 crore in the third quarter of the current fiscal, reflecting an 18 per cent year-on-year growth. All 12 public sector banks (PSBs) together made a profit of Rs 44,473 crore in the December quarter of FY25. Thus, the increase in profit in absolute terms was Rs 8,130 crore as compared to the same quarter of the previous financial year. Market leader SBI alone contributed 40 per cent to the total earnings of Rs 52,603 crore, as per the published numbers on stock exchanges. SBI posted the highest quarterly net profit of Rs 21,028 crore in Q3 FY26, 24 per cent higher than the same period of the previous fiscal. In percentage terms, Chennai-based Indian Overseas Bank reported the highest net profit growth of 56 per cent to Rs 1,365 crore, followed by Central Bank of India with a 32 per cent rise to Rs 1,263 crore. During the quarter, all 12 public sector bank

Public sector banks post 18% growth to record ₹52,603 cr profit in Q3 FY26
Updated On : 09 Feb 2026 | 6:07 PM IST

GlaxoSmithKline Pharma Q3 profit up 29 pc at Rs 296 cr

GlaxoSmithKline Pharmaceuticals on Monday posted 29 per cent increase in consolidated profit after tax at Rs 296 crore for the third quarter ended December 31, 2025. The drugmaker reported a profit after tax of Rs 230 crore for the October-December period of last fiscal. Revenue from operations rose to Rs 1,041 crore from Rs 949 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals Ltd said in a regulatory filing. The company said its competitive performance comes against the backdrop of the broader macro environment and efforts to mitigate internal supply challenges. The implementation of the new Labour Codes did not have a material impact on the company, it added. Shares of the company on Monday settled 1.01 per cent up at Rs 2,511 apiece on BSE.

GlaxoSmithKline Pharma Q3 profit up 29 pc at Rs 296 cr
Updated On : 09 Feb 2026 | 4:31 PM IST

Sterlite Technologies zooms 66% in 10 days, stock hits 18-month high

STL is at the intersection of 3 powerful multiyear investment cycles, FTTx, data centers and 5G, creating a strong structural tailwind of optical infrastructure.

Sterlite Technologies zooms 66% in 10 days, stock hits 18-month high
Updated On : 09 Feb 2026 | 3:09 PM IST

SCI jumps 19% to 2-mth high as Q3 net profit surges; buy or book profit?

The scrip increased as much as 18.9 per cent to the day's high of ₹264, the highest level since November 18, 2025

SCI jumps 19% to 2-mth high as Q3 net profit surges; buy or book profit?
Updated On : 09 Feb 2026 | 2:38 PM IST

Zydus Life Q3 result: Profit up marginally at ₹1,042 cr, revenue jumps 32%

Zydus Life Q3 Ebitda for the quarter was ₹1,816.4 crore, up 31 per cent Y-o-Y. Ebitda margin during the same period stood at 26.5 per cent, marking an improvement of 20 basis points

Zydus Life Q3 result: Profit up marginally at ₹1,042 cr, revenue jumps 32%
Updated On : 09 Feb 2026 | 2:28 PM IST

Tata, JSW, Jindal Steel at new high; rally up to 18% in 1 month; here's why

India's steel consumption to grow by 8 per cent- 9 per cent in the next few years, aided by strong demand from the infrastructure, construction and manufacturing sectors, believe analysts.

Tata, JSW, Jindal Steel at new high; rally up to 18% in 1 month; here's why
Updated On : 09 Feb 2026 | 2:11 PM IST

Hindustan Zinc, JNCASR develop zinc-ion battery prototype; stock rises 3%

Shares of Hindustan Zinc rose on Monday as the company developed, in collaboration with the JNCASR, stable and reliable zinc-ion battery pouch cell prototypes for large-scale renewable energy storage

Hindustan Zinc, JNCASR develop zinc-ion battery prototype; stock rises 3%
Updated On : 09 Feb 2026 | 1:17 PM IST

Kalyan Jewellers share price jumps 12% after Q3 net profit surges 90% YoY

The scrip jumped 11.7 per cent to the day's high of ₹424.70 on the National Stock Exchange (NSE)

Kalyan Jewellers share price jumps 12% after Q3 net profit surges 90% YoY
Updated On : 09 Feb 2026 | 11:37 AM IST